Asia-Pacific's In-Vitro Fertilization (IVF) Market 2019-2029: Anticipated to Grow at a CAGR of 10.13%

8/23/2019, 5:54 PM (Source: GlobeNewswire)

Dublin, Aug. 23, 2019 (GLOBE NEWSWIRE) -- The "Asia-Pacific In-Vitro Fertilization Market: Focus on Device Type, Reagent Type, Services, Procedure Type, End Users, Six Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029" report has been added to's offering.

The In-Vitro Fertilization (IVF) market is a well-established, multi-billion dollar market consisting of wide range of devices, reagents, and pharmaceuticals used in the complex series of IVF process. Increasing rate of infertility across the globe is a key factor responsible for the growth of IVF market.

The Asia-Pacific IVF market is valued at $6.99 billion in 2018, and is expected to witness a CAGR of 10.13% during the forecast period between 2019 and 2029.

Among the different products available in the market, services contributed to the highest market share of the Asia-Pacific IVF market in 2018. However, pharmaceuticals are expected to witness the highest CAGR, out of all other product types, during the forecast period between 2019 and 2029.

Presence of a significant number of pharmaceutical companies in the market offering their products coupled with the research and development undergoing to improve the efficiency of these pharmaceuticals attribute to the highest CAGR displayed by the artificial pancreas market. Based on end user, fertility clinics occupied the highest market share, whereas cryobanks demonstrated the potential to register the highest growth rate during the forecast.

By countries, China registered the highest market share in 2018 followed by Japan. The high Chinese population and the low fertility rate of the countries have resulted in the high adoption of IVF treatment, which in turn has contributed significantly to the Asia-Pacific IVF market. Further, the relaxation of one child policy in addition to the support extended by the Chinese government encouraging fertility treatment has enormously facilitated the growth of the China IVF market.

Significant support from the Japanese government and high disposable income among the Japanese population contributed to the growth of the IVF market in Japan. However, out of all the countries of Asia-Pacific, India is expected to register the highest CAGR of 12.09% during the forecast period between 2019 and 2029. The changing lifestyle in the urban areas of India and increasing trends toward delaying pregnancy are some of the drivers propelling the growth of the IVF market in India.

Key Topics Covered

Executive Summary

1 Market Overview
1.1 Introduction to In-Vitro Fertilization (IVF) and its Benefits
1.2 Evolution of IVF
1.3 Steps Involved in IVF
1.4 Additional IVF Procedures
1.5 Key Trends of IVF in the Asia-Pacific Market
1.6 Assumptions and Limitations

2 Market Dynamics
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Growth in Median Age of First-Time Motherhood and Declining Fertility Rates
2.3.2 High Success Rate of IVF Treatment
2.3.3 Increasing Demand for Infertility Treatment to Support Aging Population
2.3.4 Impact of Fertility Tourism
2.4 Market Challenges
2.4.1 Unaffordable Cost of Assisted Reproductive Techniques (ART) in Low- and Middle- Income Countries
2.4.2 Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in some Under-Developed and Developing Nations
2.4.3 Embryo Smuggling Cases Affecting IVF Services Market
2.5 Market Opportunities
2.5.1 Technological Advancements of Time-Lapse Technology
2.5.2 Advances in Embryo Biopsy and Genetic Screening

3 Competitive Landscape
3.1 Key Developments and Strategies
3.1.1 Agreements, Collaborations and Partnerships
3.1.2 Mergers and Acquisitions
3.1.3 Launches
3.1.4 Rewards and Recognitions
3.1.5 Business Expansions, Regulatory Approvals, and Others
3.2 Market Share Analysis

4 Regulatory Framework
4.1 Overview
4.2 Legal Requirements and Framework at International Level
4.2.1 International Federation of Gynecology and Obstetrics (FIGO)
4.2.2 International Federation of Fertility Societies (IFFS)
4.3 Legal Requirements and Framework at Regional Level (Asia-Pacific)
4.3.1 Asia Pacific Initiative on Reproduction (ASPIRE)
4.4 Legal Requirements and Framework at Country Level (of Asia-Pacific Region)
4.4.1 Fertility Society of Australia (FSA)
4.4.2 Victorian Assisted Reproductive Treatment Authority (VARTA)
4.4.3 Indian Council of Medical Research (ICMR)
4.4.4 The Medical Council of India
4.4.5 Fertility Preservation Society of India
4.4.6 China's Ministry of Health (CMOH)
4.4.7 Japan Society of Obstetrics and Gynecology (JSOG)
4.4.8 Ministry of Health (MOH), Singapore
4.4.9 Ministry of Health (MOH), Malaysia
4.4.10 Medical Council of Thailand

5 Asia-Pacific IVF Market (by Product Type)
5.1 Overview
5.2 Devices
5.2.1 Gamete Collection and Sorting Systems
5.2.2 Sample Handling Systems
5.2.3 Storage and Maintenance Systems
5.2.4 Consumables
5.2.5 Other IVF Equipment
5.3 Reagents
5.3.1 Embryo Culture Reagents
5.3.2 Cryopreservation Reagents
5.3.3 Gamete Processing Reagents
5.3.4 Others
5.4 Pharmaceuticals
5.5 Services

6 Asia-Pacific IVF Market (by End Users)
6.1 Overview
6.2 Fertility Clinics
6.3 Hospitals
6.4 Clinical Research Centers
6.5 Cryobanks

7 Asia-Pacific IVF Market (by Procedure)
7.1 Overview
7.2 Fresh Donor
7.3 Fresh Nondonor
7.4 Frozen Donor
7.5 Frozen Nondonor

8 Asia-Pacific IVF Market (by Country)
8.1 Overview
8.2 India
8.3 Japan
8.4 China
8.5 Australia and New Zealand
8.6 Singapore
8.7 South Korea
8.8 Rest-of-Asia Pacific

9 Company Profiles

  • Adorefem Gynec Pro-Infertility Division
  • Bangkok IVF Center
  • Cook Medical
  • Esco Group of Companies
  • FUJIFILM Irvine Scientific
  • Ferring Pharmaceuticals
  • Fertility First
  • Hunter Scientific Limited
  • IVFtech ApS
  • Labotect Labor-Technik-Gttingen GmbH
  • Merck KGaA
  • Olympus Corporation
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.